As news emerged about positive COVID-19 vaccine trial results, the attention turned to how the vaccine would be distributed and administered to 330 million Americans. EnlivenHealth™ explored these COVID-19 vaccine readiness issues in a recent national survey.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.